Jonathan Wong

Jonathan Wong

The Latest

  • FTC's Defeat Against Microsoft: A Dark Horizon for New Era Antitrust Enforcement, But the Fight Is Far From Over
    EXPANDING
    This Tuesday, a judge in San Francisco dealt a heavy blow to the Federal Trade Commission (FTC), the United States antitrust regulator, by rejecting its injunction request. The decision allows Microsoft to proceed with the largest acquisition in the history of the video game industry, that of Activision Blizzard.
  • Trump's Immunity Claim Rejected: E. Jean Carroll's Defamation Case Moves Forward
    Former U.S. President Donald Trump
    In a significant development, the U.S. Department of Justice (DOJ) has reversed its stance on the immunity of former President Donald Trump from a defamation lawsuit filed by writer E. Jean Carroll. The lawsuit pertains to Trump's denial of Carroll's sexual assault allegations while he was in office.
  • FBI Director Wray Stands Firm Amidst GOP Criticism in House Judiciary Hearing
    FBI Director Wray Stands Firm Amidst GOP Criticism in House Judiciary Hearing
    In a recent House Judiciary Committee hearing, FBI Director Christopher Wray faced a barrage of criticism from House Republicans, who outlined a series of grievances. Despite the onslaught, Wray remained resolute, defending the FBI's work and its commitment to impartiality.
  • Threads' Meteoric Rise: 100 Million Users in Five Days, But Twitter Remains Unthreatened
    BIAS?
    Gaining an initial user base is a common pain point for most startups: How does a new app obtain its first group of users and leverage this to reach a larger audience? Typically, it's a process of rapid iteration and persistent validation.
  • Tesla Gears Up for Affordable 'Model 2': Design Completed and Factory Ready to Break Ground
    Tesla
    The long-rumored next-generation affordable Tesla model appears to be ready to hit the market soon.
  • Lesson from Russia's Frozen Assets, Central Banks Globally Rush to Repatriate Gold
    GOLD
    An increasing number of countries are bringing their physical gold reserves back home to avoid sanctions similar to those imposed on Russia's foreign assets. At the same time, they are purchasing more precious metals as a hedge against high inflation.
  • Binance Grapples with Regulatory Pressure: Key Executives Depart and Major U.S. Layoffs
    CZ
    As regulatory scrutiny from the United States escalates, cryptocurrency exchange Binance has been hit by a wave of internal turmoil. The company has seen an exodus of key executives, including its general counsel, chief strategy officer, investigations director, and senior vice president in charge of compliance over the last few weeks. Binance also conducted a series of layoffs last week, planning to decrease its U.S. workforce to limit its exposure in the country.
  • Tightening Grip on Labor Market: U.S. Job Growth Slows, Unemployment Dips to 3.6%
    U.S. weekly jobless claims
    In the latest employment report by the Labor Department, U.S. nonfarm payrolls rose by 209,000 in June, marking a significant slowdown from May's revised figure of 306,000. While the job growth rate fell short of the predicted 225,000 by Reuters' economists, the unemployment rate shrank to 3.6% from 3.7% in the previous month.
  • Global Gold Rush: World Central Banks Continue to Stockpile, Gold Prices Set for a Potential Rise
    Gold
    The World Gold Council (WGC) has released new data indicating a continuation of gold acquisitions by central banks worldwide, with Turkey being the notable exception due to its extensive sell-off. The data shows that in May, eight central banks increased their gold reserves with a net purchase of 50 tons. However, Turkey's decision to sell another 63 tons of gold in May led to a net decrease of 27 tons in the global gold holdings of central banks.
  • A New Hope for Alzheimer's Treatment: FDA Approves Leqembi, Paving the Way for Insurance Coverage
    MEMORY LOSS
    The U.S. Food and Drug Administration (FDA) granted approval for Leqembi, an Alzheimer's disease drug developed by Japanese pharmaceutical company Eizai and Massachusetts-based Biogen on Thursday, July 6.
Prev131   132   133   134   135   136   137   138   139   140  Next